S&P 500   3,691.55 (+0.68%)
DOW   30,125.54 (+0.52%)
QQQ   305.26 (+0.32%)
AAPL   121.92 (-0.83%)
MSFT   214.10 (-0.07%)
FB   280.15 (-0.60%)
GOOGL   1,822.92 (+0.06%)
AMZN   3,173.92 (-0.40%)
TSLA   593.88 (+0.08%)
NVDA   538.98 (+0.59%)
BABA   267.29 (+0.14%)
CGC   29.01 (+1.33%)
GE   10.73 (+1.23%)
MU   73.24 (+4.78%)
AMD   93.72 (+1.53%)
T   29.57 (+1.16%)
NIO   43.57 (-3.93%)
F   9.38 (+1.85%)
ACB   11.86 (+5.52%)
BA   232.14 (-2.13%)
NFLX   498.16 (+0.13%)
GILD   61.31 (+0.74%)
DIS   153.69 (+0.29%)
S&P 500   3,691.55 (+0.68%)
DOW   30,125.54 (+0.52%)
QQQ   305.26 (+0.32%)
AAPL   121.92 (-0.83%)
MSFT   214.10 (-0.07%)
FB   280.15 (-0.60%)
GOOGL   1,822.92 (+0.06%)
AMZN   3,173.92 (-0.40%)
TSLA   593.88 (+0.08%)
NVDA   538.98 (+0.59%)
BABA   267.29 (+0.14%)
CGC   29.01 (+1.33%)
GE   10.73 (+1.23%)
MU   73.24 (+4.78%)
AMD   93.72 (+1.53%)
T   29.57 (+1.16%)
NIO   43.57 (-3.93%)
F   9.38 (+1.85%)
ACB   11.86 (+5.52%)
BA   232.14 (-2.13%)
NFLX   498.16 (+0.13%)
GILD   61.31 (+0.74%)
DIS   153.69 (+0.29%)
S&P 500   3,691.55 (+0.68%)
DOW   30,125.54 (+0.52%)
QQQ   305.26 (+0.32%)
AAPL   121.92 (-0.83%)
MSFT   214.10 (-0.07%)
FB   280.15 (-0.60%)
GOOGL   1,822.92 (+0.06%)
AMZN   3,173.92 (-0.40%)
TSLA   593.88 (+0.08%)
NVDA   538.98 (+0.59%)
BABA   267.29 (+0.14%)
CGC   29.01 (+1.33%)
GE   10.73 (+1.23%)
MU   73.24 (+4.78%)
AMD   93.72 (+1.53%)
T   29.57 (+1.16%)
NIO   43.57 (-3.93%)
F   9.38 (+1.85%)
ACB   11.86 (+5.52%)
BA   232.14 (-2.13%)
NFLX   498.16 (+0.13%)
GILD   61.31 (+0.74%)
DIS   153.69 (+0.29%)
S&P 500   3,691.55 (+0.68%)
DOW   30,125.54 (+0.52%)
QQQ   305.26 (+0.32%)
AAPL   121.92 (-0.83%)
MSFT   214.10 (-0.07%)
FB   280.15 (-0.60%)
GOOGL   1,822.92 (+0.06%)
AMZN   3,173.92 (-0.40%)
TSLA   593.88 (+0.08%)
NVDA   538.98 (+0.59%)
BABA   267.29 (+0.14%)
CGC   29.01 (+1.33%)
GE   10.73 (+1.23%)
MU   73.24 (+4.78%)
AMD   93.72 (+1.53%)
T   29.57 (+1.16%)
NIO   43.57 (-3.93%)
F   9.38 (+1.85%)
ACB   11.86 (+5.52%)
BA   232.14 (-2.13%)
NFLX   498.16 (+0.13%)
GILD   61.31 (+0.74%)
DIS   153.69 (+0.29%)
Log in
NYSE:AMRX

Amneal Pharmaceuticals Earnings Date, Estimates & History

$4.16
+0.06 (+1.46 %)
(As of 12/4/2020 12:30 PM ET)
Add
Compare
Today's Range
$4.08
Now: $4.16
$4.18
50-Day Range
$3.95
MA: $4.45
$5.42
52-Week Range
$2.40
Now: $4.16
$5.79
Volume12,693 shs
Average Volume1.54 million shs
Market Capitalization$1.25 billion
P/E Ratio10.15
Dividend YieldN/A
Beta1.24

Earnings

Amneal Pharmaceuticals (NYSE:AMRX) Earnings Information

Amneal Pharmaceuticals last announced its quarterly earnings results on November 6th, 2020. The reported $0.16 earnings per share for the quarter, beating analysts' consensus estimates of $0.12 by $0.04. The company earned $519.30 million during the quarter, compared to analysts' expectations of $482.22 million. Its revenue was up 37.3% compared to the same quarter last year. Amneal Pharmaceuticals has generated $0.27 earnings per share over the last year and currently has a price-to-earnings ratio of 10.1. Amneal Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 24th, 2021 based off prior year's report dates.

Amneal Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Amneal Pharmaceuticals (NYSE:AMRX) Earnings Estimates

2020 EPS Consensus Estimate: $0.51
2021 EPS Consensus Estimate: $0.62
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20204$0.06$0.09$0.08
Q2 20204$0.07$0.11$0.09
Q3 20204$0.08$0.29$0.16
Q4 20204$0.09$0.31$0.18
Q1 20211$0.10$0.10$0.10
Q2 20211$0.14$0.14$0.14
Q3 20211$0.18$0.18$0.18
Q4 20211$0.20$0.20$0.20

Amneal Pharmaceuticals (NYSE AMRX) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
2/24/2021
(Estimated)
       
11/6/20209/30/2020$0.12$0.16$0.32$482.22 million$519.30 millionTranscript
8/6/20206/30/2020$0.10$0.13$0.28$454.26 million$464.60 millionListen
5/11/20203/31/2020$0.09$0.20($0.42)$446.12 million$498.50 millionListen
2/26/2020Q4 2019$0.05$0.08$0.37$382.10 million$397.00 millionTranscript
11/6/20199/30/2019$0.13$0.04$2.03$403.90 million$378.30 millionTranscript
8/5/2019Q2 2019$0.14$0.09$0.25$420.12 million$404.60 millionN/A
5/9/2019Q1$0.18$0.11$0.59$438.18 million$446.00 millionN/A
2/28/2019Q4 2018$0.26$0.32$0.71$478.06 million$497.53 millionN/A
11/7/2018Q3$0.27$0.28$0.47$486.01 million$476.50 millionN/A
8/9/2018Q2 2018$0.23$0.24$0.63$460.82 million$462.33 millionN/A
3/1/2018Q4 2017$0.12$0.11$4.40$196.26 million$182.91 millionN/A
11/9/2017Q3 2017$0.19$0.23$1.15$203.66 million$206.39 millionN/A
8/9/2017Q2 2017$0.14$0.18$0.64$196.14 million$202.08 millionN/A
5/10/2017Q1 2017$0.12$0.11$1.59$190.70 million$184.40 millionN/A
3/1/2017Q4 2016$0.16$0.16$4.23$219.86 million$198.42 millionN/A
11/9/2016Q3 2016$0.40$0.37$3.25$235.06 million$227.91 millionN/A
8/9/2016Q2 2016$0.33$0.21$0.46$233.63 million$172.59 millionN/A
5/10/2016Q1 2016$0.43$0.43$1.01$255.95 million$225.51 millionN/A
2/22/2016Q4 2015$0.44$0.62$1.08$225.80 million$282.09 millionN/A
11/9/2015Q3 2015$0.39$0.40$0.31$212.50 million$221.10 millionN/A
8/10/2015Q2 2015$0.35$0.34$0.71$199.53 million$214.18 millionN/A
5/11/2015Q1 2015$0.20$0.09$0.27$143.78 million$143.10 millionN/A
2/24/2015Q4 2014$0.11$0.16$0.32$124.76 million$131.21 millionN/A
11/4/2014Q3 2014$0.40$0.33$0.44$152.36 million$158.00 millionN/A
8/6/2014Q2 2014$0.39$0.60$0.70$155.85 million$188.12 millionN/A
5/1/2014Q1 2014$0.13$0.24$0.39$118.73 million$118.72 millionN/A
2/20/2014Q4 2013$0.07($0.02)$0.10$122.32 million$100.74 millionN/A
11/4/2013Q3 2013($0.06)$0.25$0.50$109.18 million$132.64 millionN/A
8/8/2013Q2 2013$0.04$0.23$0.38$118.05 million$129.63 millionN/A
5/1/2013Q1 2013$0.23$0.37($0.81)$134.39 million$148.49 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 12/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.